The UK has become the first country to approve Moderna’s new COVID-19 booster vaccine, which specifically targets the Omicron variant in addition to the original strain of the virus.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) announced on Aug. 15 that the vaccine has been found to meet the UK regulator’s standards of safety, quality, and effectiveness.
MHRA Chief Executive Dr. June Raine said that the jab was found in the clinical trial to provide “a strong immune response against the Omicron BA.1 variant as well as the original 2020 strain.”
The new “bivalent vaccine” offers “a sharpened tool in our armoury to help protect us against this disease as the virus continues to evolve,” she said….